Did you miss one of our webinars? Simply select the appropriate link below and view the recorded webinar. It will not be interactive, but you will see the chat questions the original attendees asked. For additional information on the products discussed in the webinar, explore our links to videos and other resources.
If there is an area you would like to see covered, you can request a topic of your choice.
If you are experiencing issues opening the webinar recordings, please be sure that you have the latest Adobe Flash Player installed.
Please select a webinar type
Cell-Based Assays
Drug Discovery
Genetic Identity
Genomics
Life Science
Molecular Diagnostics (MDx)
Proteomics
Cell-Based Assays
Tuesday, June 04, 2019
Christopher Eggers, PhD
An exciting application of CRISPR/Cas9-mediated gene editing is the ability to tag and measure endogenously expressed proteins while maintaining native expression levels and regulation. In this webinar, we will discuss available options for simple and efficient knock-in of a bioluminescent peptide tag to enable sensitive, homogeneous assays for measuring protein dynamics.
Genomics
Tuesday, May 14, 2019
Dr. Nidhi Nath, Doug White and Chris D'Jamoos
Development and screening of biologics can be a time-consuming process due to the volume of samples processed for cloning, isolation of plasmids and purification of candidate antibodies. This webinar will discuss how our field-based automation team can help you develop walk-away automation solutions to speed up your purification workflow.
Genetic Identity
Wednesday, May 08, 2019
Lutz Roewer, PhD
The Y-Chromosome Haplotype Reference Database (Y-HRD) includes Y-chromosome haplotype data from 135 national databases populated over the past 20 years. Y-based ancestry prediction and familial searching can provide important investigative leads. This webinar will discuss how to use the Y-HRD to facilitate statistical analyses for a range of casework applications and interpretation purposes (e.g., frequency estimation, kinship and mixture analysis and ancestry prediction).
Drug Discovery
Tuesday, April 23, 2019
Zhijie Jey Cheng, PhD, Manuela Grassi, PhD and Richard Somberg, PhD
Mechanism of action (MOA)-based bioassays are a critical component of biologics drug development. However, establishing a functional bioassay that meets the regulatory guidelines for use in potency determination and lot release can be challenging. Join our panel of bioassay experts for a live discussion on bioassay design and selection, assay optimization, and bioassay qualification for potency lot release.
Genetic Identity
Tuesday, February 12, 2019
Rachel Oefelein and Samantha Wandzek
The rise of probabilistic genotyping has driven the need for effective ways to describe the results to judges, attorneys and juries. In this webinar, Rachel Oefelein and Samantha Wandzek of DNA Labs International (DLI) will address potential questions and response options typically covered in testimony around probabilistic genotyping. They will also discuss testifying in admissibility hearings on probabilistic genotyping systems.
